申请人:Li Jim
公开号:US20110070189A1
公开(公告)日:2011-03-24
Compounds having the formula I wherein R
1
, R
2
, R
3
, R
4
, and R
5
are as defined herein are Hepatitis C virus NS5b polymerase inhibitors. Also disclosed are compositions and methods for treating an HCV infection and inhibiting HCV replication.
具有化学式I的化合物,其中R1、R2、R3、R4和R5的定义如本文所述,是丙型肝炎病毒NS5b聚合酶抑制剂。还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。